English

Artimplant Interim Report January 1 – March 31, 2007

Report this content

Västra Frölunda, Sweden, May 3, 2007

• Net revenue of SEK 3.9 million (1.1)*
• Net loss of SEK 2.9 million (10.4)
• Earnings per share of SEK -0.05 (SEK -0.17)
• Strong sales increase for Artelon® CMC Spacer – around 1,300 (400) units were sold to end-customers during Q1 2007
• More than 4,000 patients had been treated with Artelon® devices through to Q1 2007


* Figures in brackets refer to the corresponding period last year.

The Company will not hold any conference call this quarter.

Documents & Links